Dr. Maness-Harris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
988102 Nebraska Medical Ctr
Omaha, NE 68198Phone+1 402-559-5600Fax+1 402-559-4835
Education & Training
University of ColoradoFellowship, Hematology and Medical Oncology, 2000 - 2003
University of ConnecticutResidency, Internal Medicine, 1997 - 2000
SUNY Upstate Medical UniversityClass of 1997
Certifications & Licensure
NE State Medical License 2003 - 2026
CO State Medical License 2001 - 2003- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Clinical Trials
- Cytogenetic Studies in Acute Leukemia and Multiple Myeloma Start of enrollment: 1984 Jun 01
- Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes Start of enrollment: 2007 May 07
- Efficacy Study of Oral Sapacitabine to Treat Acute Myeloid Leukemia in Elderly Patients Start of enrollment: 2007 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- 44 citationsPracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 studyGuillermo Garcia-Manero, Yasmin Abaza, Koichi Takahashi, Bruno C. Medeiros, Martha Arellano
Blood Advances. 2019-02-26 - 2 citationsSplit dose ATG strategy prevents grade III-IV acute GVHD and is associated with immune surrogates of GVL.Zaid Al-Kadhimi, Samuel Pirruccello, Zartash Gul, Lori Maness-Harris, Vijaya Raj Bhatt
Bone Marrow Transplantation. 2022-10-01 - 9 citationsUrothelial Cell Intracytoplasmic Inclusions After Treatment of Promyelocytic Leukemia With Arsenic TrioxideWhitney Wedel, David Muirhead, Lora L. Arnold, Puttappa R. Dodmane, Subodh M. Lele
Toxicological Sciences. 2013-08-01
Abstracts/Posters
- Effect of Using Multiagent Versus Single Agent Chemotherapy on Overall Survival (OS) of Older Adults with Acute Myeloid Leukemia (AML)Lori J. Maness, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Integrating Geriatric Assessment and Genetic Profiling to Personalize Therapy Selection in Older Adults with Acute Myeloid Leukemia (AML)Lori J. Maness, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
